Clinical Trial Update: A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer(PANKU-Breast02) [Phase 3]

View source ↗

Summary

Phase 3 study comparing BL-B01D1 to physician's choice chemotherapy in unresectable locally advanced or metastatic triple-negative breast cancer; currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• BL-B01D1

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Triple-Negative Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING